Effect of antiplatelet and anticoagulant medication use on injury severity and mortality in patients with traumatic brain injury treated in the intensive care unit - Takeaways - MDSpire

Effect of antiplatelet and anticoagulant medication use on injury severity and mortality in patients with traumatic brain injury treated in the intensive care unit

  • By

  • Juho Vehviläinen

  • Jyri J. Virta

  • Markus B. Skrifvars

  • Matti Reinikainen

  • Stepani Bendel

  • Tero Ala-Kokko

  • Sanna Hoppu

  • Ruut Laitio

  • Jari Siironen

  • Rahul Raj

  • November 1, 2023

  • 0 min

Share

  • 1

    Traumatic brain injury (TBI) is a leading cause of mortality among young people and a significant risk factor for the elderly.

  • 2

    Anticoagulant medication, particularly warfarin, significantly increases TBI mortality, while direct oral anticoagulants do not raise in-hospital mortality in mild cases.

  • 3

    Antiplatelet medication is associated with minimal to no increase in mortality among TBI patients, highlighting its different impact compared to anticoagulants.

  • 4

    The Helsinki CT score is favored for assessing TBI severity due to its simplicity and effectiveness in predicting outcomes.

  • 5

    The study aims to evaluate the effects of antiplatelet and anticoagulant medications on TBI severity and 1-year mortality in ICU patients.

Original Source(s)

Related Content